Showing results (991-1000 of 6,888) with videos related to

Sort By:
Pageof 689
Clinical and Experimental Pharmacology & Physiology|June 4, 2008
Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS)Stephanie-May Ruchat, Martine Girard, S John Weisnagel, et al.
Clinical and Experimental Pharmacology & Physiology|June 4, 2008
Alveolar-arterial oxygen gradient, pneumonia severity index and outcomes in patients hospitalized with community acquired pneumoniaMahmoud Q Moammar, Hamad M Azam, Adel I Blamoun, et al.
Clinical and Experimental Pharmacology & Physiology|May 24, 2008
Sheep models of intrauterine growth restriction: fetal adaptations and consequencesJanna L Morrison
Clinical and Experimental Pharmacology & Physiology|January 9, 2025
Diclofenac Enhances the Response of BRAF Inhibitor to Melanoma Through ROS/p38/p53 SignalingHaihong Qin, Zheng Li, Jinfeng Wu, et al.
Clinical and Experimental Pharmacology & Physiology|November 20, 2024
TLR4 Inhibitor TAK-242 Protected Henoch-Schonlein Purpura Nephritis in Rats by Regulating Inflammatory Response and Immune Competence via NF- κB/NLRP3 SignallingYirong Liu, Qiong Wu, Zhenxing Huang, et al.
Clinical and Experimental Pharmacology & Physiology|September 16, 2024
Phillygenin attenuates cell apoptosis and microglia activation in cerebral ischaemia-reperfusion rats through activation of peroxisome proliferator-activated receptor γChaojun Yan, Guangwei Sun, Changlong Hu, et al.
Clinical and Experimental Pharmacology & Physiology|October 28, 2024
Odoratin balances ROS/NO through EZH2/PPARγ signalling to improve myocardial fibrosisBin Rao, Min Zhang, Min Liu, et al.
Clinical and Experimental Pharmacology & Physiology|October 24, 2024
Caffeic acid phenethyl ester ameliorates colistin-induced nephrotoxicity in rats via modulation of FOXO1/Nrf2/Sirt1 axisMohammed Z Nasrullah, Thikryat Neamtalllah, Mohannad Alshibani, et al.
Clinical and Experimental Pharmacology & Physiology|February 19, 2025
Flavokawain A Ruthenium-p-Cymene Complex-Induced Apoptosis by the Modulation of PI3K/β-Catenin/HER2/PARP Signalling in Lung CancerSakuntala Gayen, Souvik Roy, Diana Laishram, et al.
Clinical and Experimental Pharmacology & Physiology|February 10, 2025
Development and Validation of a Comprehensive Risk Prediction Model for Polypoid Lesions of the GallbladderChunxu Dou, Yanzhi Han, Lu Lin, et al.
Pageof 689